Alyeska Investment Group
CVAC

Alyeska Investment Group’s CureVac CVAC Stock Holding History

Alyeska Investment Group’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-500,000
Closed -$1.71M – 540
2024
Q4 		$1.71M Buy
500,000
+100,000
+25% +$288K 0.01% 470
2024
Q3 		$1.18M Buy
+400,000
New +$1.32M 0.01% 452
2024
Q1 		– Sell
-1,632,490
Closed -$6.87M – 497
2023
Q4 		$6.87M Buy
1,632,490
+399,913
+32% +$2.17M 0.05% 287
2023
Q3 		$8.42M Buy
1,232,577
+333,154
+37% +$2.94M 0.06% 302
2023
Q2 		$9.37M Sell
899,423
-160,959
-15% -$1.44M 0.07% 271
2023
Q1 		$7.39M Buy
+1,060,382
New +$9.24M 0.06% 271

Other funds holding CVAC

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Alyeska Investment Group's CVAC Position: Q1 2025 in Review

Alyeska Investment Group sold out of CureVac (CVAC) in Q1 2025, closing a stake of 500,000 shares — an estimated $1.71M sold.

Alyeska Investment Group first reported a position in CVAC in Q1 2023 and held it in 6 quarters. The position peaked at $9.37M in Q2 2023. 83 funds tracked by Wall St. Rank hold CVAC as of Q1 2025.

  • Alyeska Investment Group reported no remaining CureVac position as of Q1 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 500,000 CureVac shares in Q1 2025, an estimated $1.71M.
  • Alyeska Investment Group first reported a position in CureVac in Q1 2023 and held it in 6 quarters.
  • Alyeska Investment Group's CureVac position peaked at $9.37M in Q2 2023.
  • 83 funds tracked by Wall St. Rank held CureVac as of Q1 2025.

Based on Alyeska Investment Group's 13F filing for Q1 2025, filed 15 May 2025.